Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

Transplant Infectious Disease

Volumn 16, Issue 1, 2014, Pages 106-114

  Blennow, O ^a,b   Ljungman, P ^a,b   Sparrelid, E ^a   Mattsson, J ^a,b   Remberger, M ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allogeneic; Bloodstream infection; BSI; HSCT; Pre engraftment neutropenia

Indexed keywords

ALLOGENEIC; BLOODSTREAM INFECTION; BSI; HSCT; PRE-ENGRAFTMENT NEUTROPENIA;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTI-INFECTIVE AGENTS; BACTEREMIA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COHORT STUDIES; ENTEROCOCCUS; FEMALE; FLUCONAZOLE; FUNGEMIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VIRIDANS STREPTOCOCCI; YOUNG ADULT;

EID: 84893845591     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12175     Document Type: Article

References (24)

1. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007; 40 (1): 63-70.
2. Mikulska M, Del Bono V, Raiola AM, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009; 15 (1): 47-53.
3. Almyroudis NG, Fuller A, Jakubowski A, et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2005; 7 (1): 11-17.
4. Kumar A, Ellis P, Arabi Y, et al.; Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136 (5): 1237-1248.
5. Oliveira AL, de Souza M, Carvalho-Dias VM, et al. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007; 39 (12): 775-781.
6. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001; 33 (7): 947-953.
7. Sparrelid E, Hägglund H, Remberger M, et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22 (8): 795-800.
8. Svahn BM, Remberger M, Myrbäck KE, et al.; Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002; 100 (13): 4317-4324.
9. Lundgren G, Wilczek H, Lönnqvist B, Lindholm A, Wahren B, Ringdén O. Acyclovir prophylaxis in bone marrow transplant recipients. Scand J Infect Dis Suppl 1985; 47: 137-144.
10. Kahlmeter G, Olsson-Liljequist B, Ringertz S. Antimicrobial susceptibility testing in Sweden. IV. Quality assurance. Scand J Infect Dis Suppl 1997; 105: 24-31.
11. Poutsiaka DD, Munson D, Price LL, Chan GW, Snydman DR. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 2011; 46 (2): 300-307.
12. Hellman J, Norman C, Olsson-Liljequist B. A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine, in Swedes 2010. Swedish Institute for Communicable Disease Control: Stockholm, 2011.
13. Kjellander C, Björkholm M, Cherif H, Kalin M, Giske CG. Hematological: low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study. Eur J Haematol 2012; 88 (5): 422-430.
14. Martino R, Caballero MD, Canals C, et al. alloPBSCT and Infectious/noninfectious Complications Subcommittees of the Grupo Español de Transplante Hematopoyético (GETH). Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28 (4): 341-347.
15. Engelhard D, Elishoov H, Or R, et al. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study. Bone Marrow Transplant 1995; 16 (4): 565-570.
16. Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000; 31 (5): 1126-1130.
17. Freifeld AG, Bow EJ, Sepkowitz KA, et al.; Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52 (4): e56-e93.
18. Vydra J, Shanley RM, George I, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55 (6): 764-770.
19. Mikulska M, Del Bono V, Prinapori R, et al. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2010; 12 (6): 505-512.
20. Suppola JP, Volin L, Valtonen VV, Vaara M. Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 1996; 23 (4): 694-697.
21. Ringden O, Labopin M, Bacigalupo A, et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002; 20 (24): 4655-4664.
22. Rocha V, Labopin M, Sanz G, et al.; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351 (22): 2276-2285.
23. Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101 (4): 1620-1629.
24. Vela-Ojeda J, García-Ruiz EM, Tripp-Villanueva F, et al. Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia. Stem Cells Dev 2004; 13 (5): 571-579.